Skip to main content
Log in

Alterations in the heart sarcolemmal Ca2+ transport activity by some β-adrenergic antagonists

  • Original Contributions
  • Published:
Basic Research in Cardiology Aims and scope Submit manuscript

Summary

The effects of some β-adrenergic antagonists such as acebutolol, propranolol, pindolol and oxprenolol (1–1000 μM) were studied on the rat heart sarcolemmal Ca2+ transport activities. Pindolol enhanced sarcolemmal ATP-dependent Ca2+ binding and Ca2+-stimulated ATPase whereas acebutolol had no effect. Both propranolol and oxprenolol had biphasic actions on the sarcolemmal Ca2+ pump activities; the lower concentrations (1 and 10 μM) were stimulatory, but the higher concentrations (100 and 1000 μM) were inhibitory. None of the drugs used in this study had any effect on Mg2+ ATPase and non-specific Ca2+ binding activities of heart sarcolemma except that 1000 μM propranolol decreased Mg2+ ATPase activity significantly. Mitochondrial and microsomal ATP-dependent Ca2+ binding activities were unaffected by these drugs (1–1000 μM), except that 1000 μM propranolol was inhibitory. These results suggest differences among various β-adrenergic blocking drugs with respect to their actions on sarcolemmal Ca2+ pump in the myocardium.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Caroni P, Carafoli E (1980) An ATP-dependent Ca2+-pumping system in dog heart sarcolemma. Nature (London) 283:765–767

    Article  Google Scholar 

  2. Caroni P, Carafoli E (1981) The Ca2+-pumping ATPase of heart sarcolemma. Characterization, calmodulin dependence, and partial purification. J Biol Chem 256:3263–3270

    PubMed  Google Scholar 

  3. Dhalla NS (1976) Involvement of membrane systems in heart failure due to intracellular calcium overload and deficiency. J Mol Cell Cardiol 8:661–667

    Article  Google Scholar 

  4. Dhalla NS, Lee SL (1976) Comparison of the actions of acebutolol, practolol and propranolol on calcium transport by heart microsomes and mitochondria. Br J Pharmac 57:215–221

    Google Scholar 

  5. Dhalla NS, Ziegelhoffer A, Harrow JAC (1977) Regulatory role of membrane systems in heart function. Can J Physiol Pharmacol 55:1211–1234

    PubMed  Google Scholar 

  6. Dzurba A, Ganguly PK, Beamish RE, Dhalla NS (1983) Stimulation of calcium pump activity in heart sarcolemma by timolo. Can J Physiol Pharmacol 61:240–244

    PubMed  Google Scholar 

  7. Hess ML, Briggs FN, Shinebourne E, Hamer J (1968) Effect of adrenergic blocking agents on the calcium pump of the fragmented cardiac sarcoplasmic reticulum. Nature (London) 220:79–80

    Google Scholar 

  8. Levy JV (1971) Cardiovascular effects of pindolol (LB-46), a potent beta-adrenergic receptor antagonist. J Clin Pharmacol 2:249–260

    Google Scholar 

  9. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275

    PubMed  Google Scholar 

  10. Mas-Oliva J, Nayler WG (1980) The effect of verapamil on the Ca2+-transporting and Ca2+-ATPase activity of isolated cardiac sarcolemmal preparations. Br J Pharmac 70:617–624

    Google Scholar 

  11. Meltzer HL, Kassir S (1983) Inhibition of calmodulin-activated Ca2+-ATPase by propranolol and nadolol. Biochim Biophys Acta 755:452–456

    PubMed  Google Scholar 

  12. Morcos NC, Drummond GI (1980) Ca2+ Mg2+ ATPase in enriched sarcolemma from dog heart. Biochim Biophys Acta 598:27–39

    PubMed  Google Scholar 

  13. Nayler WG, Poole-Wilson PA, Williams A (1979) Hypoxia and calcium. J Mol Cell Cardiol 11:683–706

    PubMed  Google Scholar 

  14. Noack E, Kurzmack M, Verjovski-Almeida S, Inesi G (1978) The effect of propranolol and its analogs on Ca2+ transport by sarcoplasmic reticulum vesicles. J Pharmacol Exp Ther 206:281–288

    PubMed  Google Scholar 

  15. Phillips DK (1980) Adrenergic activators and inhibitors. Part 1. Springer-Verlag, Berlin Heidelberg New York

    Google Scholar 

  16. St. Louis PJ, Sulakhe PV (1976) Isolation of sarcolemmal membranes from cardiac muscle. Int J Biochem 7:547–558

    Article  Google Scholar 

  17. Sulakhe PV, Leung NL-K, St. Louis PJ (1976) Stimulation of calcium accumulation of cardiac sarcolemma by protein kinase. Can J Biochem 54:438–445

    PubMed  Google Scholar 

  18. Taussky HH, Shorr E (1953) A microcolorimetric method for the determination of inorganic phosphorus. J Biol Chem 202:675–685

    PubMed  Google Scholar 

  19. Temple D, Hasselbach W, Makinose M (1974) The inhibition by β-adrenoreceptor blocking agents of calcium uptake into and efflux from isolated sarcoplasmic vesicles. Naunyn Schmiedeberg's Arch Pharmacol 282:187–194

    Article  Google Scholar 

  20. Trumble WR, Sutko JL, Reeves JP (1981) Cardiac sarcolemmal and sarcoplasmic reticulum membrane vesicles exhibit distinctive (Ca−Mg)-ATPase substrate specificities. J Biol Chem 256:7101–7104

    PubMed  Google Scholar 

  21. Tuana BS, Dzurba A, Panagia V, Dhalla NS (1981) Stimulation of heart sarcolemmal calcium pump by calmodulin. Biochim Biophys Res Commun 100:1245–1250

    Article  Google Scholar 

  22. Volpi M, Shaafi RI, Feinstein MB (1981) Antagonism of calmodulin by local anaesthetics. Mol Pharmacol 20:363–370

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dzurba, A., Ganguly, P.K., Guerin, A. et al. Alterations in the heart sarcolemmal Ca2+ transport activity by some β-adrenergic antagonists. Basic Res Cardiol 79, 620–626 (1984). https://doi.org/10.1007/BF01908380

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01908380

Key Words

Navigation